We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Dual-Functional Fluorescent Probe for DNA Hybridization and Melting Point Analysis

By LabMedica International staff writers
Posted on 20 Aug 2013
Japanese researchers have described a new approach for combining real-time PCR amplification and melting curve analysis in a single-tube reaction, which provides a powerful means for new mutation detection assays.

This technology, which was jointly developed by the RIKEN Center for Life Science Technologies (Saitama, Japan) and K.K. More...
DNAFORM (Yokohama City, Japan) will enable the development of new, advanced assays for DNA-based genetic testing and should help to bring the benefits of genome-wide sequencing studies to patients in the clinic.

The new methodology is based on RIKEN's Eprobe, a highly efficient and reliable fluorescent probe. Eprobes contain two dye moieties attached to the same nucleotide, and their fluorescent signal is strongly suppressed as single-stranded oligonucleotides by an excitonic interaction between the dyes. Upon hybridization to a complementary DNA strand, the dyes are separated and intercalate into the double-strand leading to strong fluorescence signals. Furthermore, intercalation of dyes further stabilizes the DNA/DNA hybrid and increases the melting temperature compared to standard DNA oligonucleotides. Thus, Eprobes allow for specific real-time monitoring by amplification while enabling study of reaction products by melting curve analysis.

In a recent study, the investigators used Eprobes for the detection of genetic variations in a human EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) tumor. They demonstrated that Eprobes provided decisive advantages over commonly used hybridization probes because of their unique background signal reduction, enhanced DNA-binding affinity, and very low false positives rate.

"We are very excited about the potential of the new Eprobes,” said Dr. Matthias Harbers, a visiting scientist at the RIKEN Center for Life Science. "In the reactions, Eprobes acted like sequence-specific fluorescent dyes, which gives them great potential for use as hybridization probes not only in PCR and melting curve analysis but also in other important applications like, for instance, in fluorescent in situ hybridization or FISH."

The Eprobe study was published in the August 7, 2013, online edition of the journal PLOS ONE.

Related Links:

RIKEN Center for Life Science Technologies
K.K. DNAFORM



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.